|
Sanofi invests to make France its world class center of excellence in vaccine research and production
|
17 June 2020 |
|
Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration
|
26 May 2020 |
|
Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients
|
27 April 2020 |
|
Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries
|
13 April 2020 |
|
First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
|
02 April 2020 |
|
Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis
|
07 February 2020 |
|
Sanofi completes acquisition of Synthorx, Inc.
|
28 January 2020 |
|
Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing
|
15 October 2019 |
|
Educational campaign helps teens and their caregivers tackle the everyday challenges of living with moderate-to-severe atopic dermatitis
|
18 September 2019 |
|
FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma
|
10 July 2019 |